Core Viewpoint - The company is advancing its strategic development by investing in a new manufacturing facility and adjusting its fundraising projects to meet market demands, with a focus on enhancing production capacity for key pharmaceutical products. Group 1: Company Overview - The company has signed an investment cooperation agreement with the Dongyang Economic Development Zone Management Committee to invest in the "Haisen Pharmaceutical New Plant Construction Project (Phase I)" with a total investment of no less than 2 billion RMB [5]. - The company has not changed its controlling shareholder or actual controller during the reporting period [4][5]. Group 2: Financial Data and Fundraising - The company raised a total of 756.16 million RMB from its initial public offering, with a net amount of 675.72 million RMB after deducting underwriting fees and other expenses [10]. - As of June 30, 2025, the company had a balance of 7.53 million RMB in unused raised funds, with 4 million RMB allocated for permanent working capital and 3.53 million RMB for the new project [21]. Group 3: Project Updates - The company has changed its fundraising project from "Annual Production of 200 Tons of Atorvastatin Calcium Technical Transformation Project" to "Annual Production of 300 Tons of A-40 (Atorvastatin Calcium) and Other Specialty Raw Material Construction Project" to better align with market trends [6]. - The construction of the R&D center and comprehensive office building has been completed, with equipment installation ongoing, leading to a delay in the investment schedule [7]. Group 4: Profit Distribution and Capital Changes - The company approved a profit distribution plan for 2024, which includes a cash dividend of 1.70 RMB per 10 shares and a capital reserve transfer of 4.8 shares for every 10 shares held [8]. - The registered capital has increased from 102.65 million RMB to 151.93 million RMB following the implementation of the profit distribution plan [8]. Group 5: Regulatory Compliance - The company has adhered to regulations regarding the management and use of raised funds, ensuring that there are no violations in the storage, usage, and disclosure of these funds [25].

Summary of Key Points Core Viewpoint The report provides a detailed account of Dongguan Darui Electronics Co., Ltd.'s fundraising activities, including the total amount raised, the usage of funds, and the management of these funds as of June 30, 2025. It highlights the company's compliance with regulatory requirements and outlines the financial status of its fundraising projects. Fundraising Overview - The company raised a total of RMB 2,193,016,056.00 through its initial public offering, with a net amount of RMB 2,038,096,865.89 after deducting issuance costs [1] - The funds were fully received by April 12, 2021, and verified by an accounting firm [1] Fund Usage and Balance - As of June 30, 2025, the net amount of raised funds was RMB 203,809.69 million, with cumulative investments in fundraising projects totaling RMB 143,402.16 million [2] - The company invested RMB 16,792.00 million in fundraising projects during the reporting period [2] - The remaining balance of unused funds was RMB 63,419.17 million, including RMB 58,400.00 million temporarily idle for cash management [2] Fund Management - The company established a fundraising management system in compliance with relevant regulations, including a dedicated management method for the storage and use of funds [2] - Special accounts were opened for the management of fundraising funds, and a tripartite supervision agreement was signed with several banks [2][3] Cash Management - The company has been authorized to use up to RMB 11 billion of temporarily idle funds for cash management, with a subsequent approval to use up to RMB 8 billion [6] - As of June 30, 2025, the company earned RMB 518.92 million from cash management activities [8] Project Implementation and Adjustments - The "3C Electronic Assembly Automation Equipment Production Project" and "Wearable Electronic Product Structural Parts Production Project" have reached their intended usable status as of March 25, 2024, and March 25, 2025, respectively [9][10] - The company has not made any changes to the implementation locations or methods of fundraising projects as of June 30, 2025 [12] Surplus Fund Usage - Surplus funds from the projects have been permanently allocated to supplement working capital, with specific amounts detailed for each project [9][10][14] - The company has also reported on the usage of over-raised funds, with a total of RMB 56,869.28 million in surplus funds, of which RMB 1,322.72 million remains unallocated [14]

招商证券股份有限公司 关于盛视科技股份有限公司 经中国证券监督管理委员会《关于核准盛视科技股份有限公司首次公开发行 股票的批复》（证监许可[2020]663 号）文件核准，公司首次公开发行人民币普 通股（A 股）股票 3,156 万股，发行价格为人民币 36.81 元/股（不含送转），本 次募集资金总额为人民币 1,161,723,600.00 元，扣除发行费用（不含增值税）人 民币 124,963,600.00 元后，实际募集资金净额为人民币 1,036,760,000.00 元。上 述募集资金到账后，天健会计师事务所（特殊普通合伙）于 2020 年 5 月 20 日对 公司首次公开发行股票的募集资金到位情况进行了审验，并出具了《验资报告》 （天健验[2020]7-37 号）。公司与募集资金开户银行、保荐机构签署《募集资金 三方监管协议》，开立了募集资金专项账户。三方监管协议与深圳证券交易所三 方监管协议范本不存在重大差异，公司在使用募集资金时已经严格遵照履行。 （二）募投项目情况 公司首次公开发行股票募投项目及募集资金使用计划如下： 承诺使用募集 投资总额 项目达到预定 可使 序号 项目 资金金额 （万元 ...

Core Points - The report details the fundraising and usage status of Jinan Mankun Technology Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and accurate disclosure [1][4][8] Fundraising Overview - The company raised a total of RMB 988.12 million through its initial public offering, with a net amount of RMB 874.44 million after deducting issuance costs [1] - The funds were deposited into a dedicated account on August 5, 2022, and verified by Tianjian Accounting Firm [1] Fund Usage and Management - As of June 30, 2025, the company had utilized RMB 129.92 million of the raised funds, with a remaining balance of RMB 398.98 million in the dedicated account [2][4][7] - The company has established a fundraising management system and signed a tripartite supervision agreement with Agricultural Bank of China and its sponsor, Zhongtai Securities [2][4] Financial Details - The company reported a net interest income of RMB 12.74 million as of the beginning of the period, with a total of RMB 25.42 million in interest income by the end of the period [2][4] - The total amount of funds invested in projects reached RMB 500.89 million, representing 57.28% of the total committed investment [8] Project Implementation - The company has not changed the implementation location or method of its fundraising projects during the reporting period [4] - The company approved the use of RMB 50.64 million of raised funds to replace pre-invested self-raised funds and issuance costs [4][5] Idle Fund Management - The company has not used idle funds to supplement working capital as of June 30, 2025, and has plans to manage idle funds through safe and liquid investment products [5][7] - The maximum amount of idle funds used for cash management in the reporting period was RMB 550 million [7] Compliance and Reporting - The company confirmed that there were no issues with the disclosure of fundraising usage, and all information was timely and accurate [8] - There were no changes in the fundraising project or any violations in the management and disclosure of the funds [8]

Core Points - The report details the fundraising activities and usage of funds by Shanghai Jianke Consulting Group Co., Ltd, confirming compliance with regulatory requirements [1][2][4] Fundraising Overview - The company raised a total of RMB 630.85 million by issuing 55 million shares at RMB 11.47 per share, with net proceeds amounting to RMB 598.91 million after deducting issuance costs of RMB 31.94 million [1] - As of June 30, 2025, the company has utilized RMB 602.60 million of the raised funds, leaving a balance of RMB 3.06 million [2] Fund Management - The company has established a dedicated account for managing the raised funds, ensuring compliance with relevant laws and regulations [4][5] - A four-party supervision agreement was signed with the underwriters and banks to clarify the rights and obligations of all parties involved in the fund management [4] Fund Usage - The actual usage of the raised funds includes investments in core business capability enhancement projects and digital technology industry capability enhancement projects, with a total investment of RMB 602.60 million as of June 30, 2025 [3][6] - The company has not changed the intended use of the raised funds, and there are no issues reported regarding the usage and disclosure of the funds [6][7]

General Principles - The purpose of the fundraising management system is to standardize the management of funds raised by Guangxi Fenglin Wood Industry Group Co., Ltd., improve the efficiency and effectiveness of fund usage, and protect the interests of investors [1][2] - The funds raised refer to the money obtained through the issuance of stocks or other equity-like securities for specific purposes, excluding funds raised for stock incentive plans [3] Fund Management - The company must use the raised funds prudently according to the purposes listed in the prospectus and must not change the usage without proper disclosure [3][4] - The board of directors is responsible for continuously monitoring the management and usage of the raised funds to prevent investment risks and enhance fund usage efficiency [4] Fund Storage - The company is required to open a special account for the raised funds in a commercial bank, ensuring that only the raised funds are stored in this account [5][6] - If the company has multiple rounds of financing, separate special accounts must be established for each round [6] Fund Usage - The raised funds should primarily be used for the main business and cannot be used for financial investments or to provide funds to controlling shareholders or related parties [9][10] - If a fundraising project faces significant changes in market conditions or delays, the company must reassess the project's feasibility and disclose any necessary adjustments [11][12] Changes in Fund Usage - Any changes in the use of raised funds must be approved by the board of directors and disclosed to shareholders [15][16] - The company must ensure that any new projects funded by the raised funds align with its main business and enhance its competitive and innovative capabilities [22] Fund Management and Supervision - The accounting department must maintain detailed records of the usage of raised funds, and internal audits should be conducted at least biannually [25][26] - The company must cooperate with the sponsor or independent financial advisors in their ongoing supervision and audits of the raised funds [21][19]

截至 2023 年 10 月 24 日，本公司上述发行募集的资金已全部到位，业经大 华会计师事务所（特殊普通合伙）以"大华验字[2023]000618 号"验资报告验证 确认。 截至 2025 年 6 月 30 日，公司对募集资金投资项目（以下简称"募投项目"） 累计投入人民币 4,043,028,495.77 元，其中：1、募投项目累计使用募集资金人民 币 2,543,028,495.77 元，包括公司于募集资金到位之前利用自有资金先期投入募 集资金项目人民币 1,177,089,206.15 元；2、使用募集资金永久补充流动资金人民 币 1,500,000,000.00 元。 截至 2025 年 6 月 30 日，本公司使用闲置募集资金暂时补充流动资金暂未归 还金额为人民币 996,200,000.00 元。除上述支出外，本公司使用闲置募集资金置 换公司于募集资金到位之前利用自有资金支付的发行费用人民币 4,701,415.09 元， 收到募集资金专户累计利息收入扣除手续费支出后的净额人民币 1,509,814.01 元。 截至 2025 年 6 月 30 日，募集资金专户余额为人民币 14,550,49 ...

宁波东方电缆股份有限公司 募集资金管理制度 （2025 年 8 月修订） 为加强、规范募集资金的管理，确保资金使用的安全，提高其使用效率和效益， 根据《公司法》《证券法》《上市公司募集资金监管规则》、上海证券交易所（下称 "上交所"）《股票上市规则》及其他有关规定，结合宁波东方电缆股份有限公司 （以下简称"公司""本公司"）实际，特制定本制度。 第一章 总 则 第六条 募集资金投资项目（以下简称"募投项目"）通过公司的子公司或者公司 控制的其他企业实施的，公司应当确保该子公司或者受控制的其他企业遵守本制度规 定。 第二章 募集资金的存放 第七条 为方便募集资金的使用及对使用情况进行监督，公司应设立专户对募集资 金进行存储，不能与公司其他资金混合存放。上述募集资金存储专户应由董事会决 定。 第八条 公司应当在募集资金到账后一个月内与保荐机构或者独立财务顾问、存放 募集资金的商业银行（以下简称"商业银行"）签订募集资金专户存储三方监管协议 并及时公告。相关协议签订后，公司可以使用募集资金。该协议至少应当包括以下内 容： 第一条 本制度所称募集资金系指公司通过发行股票或者其他具有股权性质的证 券，向投资者募集并用于 ...

Meeting Overview - The second board meeting of Kaleite Cloud Technology Co., Ltd. was held on August 13, 2025, with all 7 directors present, complying with relevant laws and regulations [1][2]. Financial Reporting - The board approved the 2025 semi-annual report and its summary, which were prepared in accordance with the regulations set by the China Securities Regulatory Commission [1][2]. Fund Management - The board reviewed and approved a special report on the management and use of raised funds for the first half of 2025, with a unanimous vote of 7 in favor [2][3]. Fund Replacement - The company plans to use its own funds to pay for project expenses and will replace these with raised funds, which is expected to enhance fund usage efficiency without affecting project progress [3][4]. Corporate Governance - The board proposed to apply for a multi-address business license and to amend the company’s articles of association, pending approval from the shareholders' meeting [4][5]. Auditor Appointment - The board intends to reappoint Lixin Certified Public Accountants as the auditing firm for the 2025 fiscal year, subject to shareholder approval [4][5]. Upcoming Shareholder Meeting - A temporary shareholders' meeting is scheduled for September 2, 2025, to discuss the proposed resolutions [5].

广宇集团股份有限公司 募集资金使用管理办法 2025 年 8 月 广宇集团股份有限公司募集资金使用管理办法 为了规范公司募集资金的管理和使用，保护投资者的权益，依照《公司法》、 《深圳证券交易所股票上市规则》（以下简称"《股票上市规则》"）、《上市 公司募集资金监管规则》、《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》等有关法规和《公司章程》，结合公司实际情况，特制 定本办法。 第一章 总 则 第一条 本办法所称募集资金，是指公司通过公开发行证券 (包括首次公开 发行股票、配股、增发、发行可转换债券、发行分离交易的可转换公司债券、发 行权证等)以及非公开发行证券向投资者募集并用于特定用途的资金。 第二条 募集资金严格限定用于公司在发行申请文件中承诺的募集资金投资 项目。公司变更募集资金投资项目必须经过股东会批准，并履行信息披露义务和 其他相关法律义务。 第三条 公司应根据《公司法》、《证券法》、《股票上市规则》等法律、 法规和规范性文件的规定，及时披露募集资金使用情况，并在年度审计的同时聘 请会计师事务所对募集资金存放与使用情况进行鉴证。 第五条 公司控股股东、实际控制人不得直接或 ...